Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
April 25, 2024 08:05 ET
|
Shareholder Capital LLC
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
NASDAQ: VNDA Investor Notice: Update in Lawsuit against Vanda Pharmaceuticals Inc. announced by Shareholders Foundation
March 23, 2021 07:15 ET
|
Shareholders Foundation, Inc.
SAN DIEGO, March 23, 2021 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA). ...
Global Schizophrenia Drug Market is estimated to be US$ 9.8 Bn by 2030 with a CAGR of 2.7% during the forecast period - by PMI
February 24, 2021 10:05 ET
|
PMI
Covina CA, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global schizophrenia drug market accounted for US$ 7.5 Bn in 2020 and is estimated to be US$ 9.8 Bn by 2030 and is anticipated to register a CAGR of...
Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws
February 11, 2019 10:49 ET
|
Block & Leviton LLP
BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...